Data / Drug companies / Allopurinol
Allopurinol: 54 companies and 174 products in the FDA NDC directory
Allopurinol is listed in the FDA National Drug Code Directory by 54 companies, with 174 products in commercial distribution. 163 of the products (93.7%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; injection, powder, lyophilized, for solution, and the newest product started marketing on October 6, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 54
- Products
- 174
- Generic (ANDA) products
- 163 (93.7%)
- Application numbers
- 18
- Routes
- Oral, Intravenous
- Brand names
- Aloprim
- openFDA record search
- api.fda.gov
Companies that list allopurinol
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 17 | tablet | Generic drugs (ANDA) | October 31, 2023 |
| Bryant Ranch Prepack | 14 | tablet | Generic drugs (ANDA) | May 1, 2024 |
| Preferred Pharmaceuticals Inc. | 9 | tablet | Generic drugs (ANDA) | September 22, 2025 |
| Aphena Pharma Solutions - Tennessee, LLC | 8 | tablet | Generic drugs (ANDA) | May 1, 2024 |
| Remedyrepack Inc. | 8 | tablet | Generic drugs (ANDA) | July 7, 2026 |
| Northwind Health Company, LLC | 6 | tablet | Generic drugs (ANDA) | June 8, 2023 |
| Cardinal Health 107, LLC | 5 | tablet | Generic drugs (ANDA) | July 24, 2026 |
| NuCare Pharmaceuticals,Inc. | 5 | tablet | Generic drugs (ANDA) | May 1, 2024 |
| Bryant Ranch Prepack | 4 | tablet | Generic drugs (ANDA) | April 6, 2009 |
| Coupler LLC | 4 | tablet | Generic drugs (ANDA) | February 4, 2026 |
| PD-Rx Pharmaceuticals, Inc. | 4 | tablet | Generic drugs (ANDA) | January 9, 1987 |
| St. Mary's Medical Park Pharmacy | 4 | tablet | Generic drugs (ANDA) | May 1, 2024 |
| Advanced Rx of Tennessee, LLC | 3 | tablet | Generic drugs (ANDA) | May 29, 2025 |
| Direct_Rx | 3 | tablet | Generic drugs (ANDA) | October 30, 2025 |
| Florida Pharmaceutical Products, LLC | 3 | tablet | Generic drugs (ANDA) | May 22, 2025 |
| Indoco Remedies Limited | 3 | tablet | Generic drugs (ANDA) | May 15, 2024 |
| Leading Pharma, LLC | 3 | tablet | Generic drugs (ANDA) | September 1, 2024 |
| Proficient Rx LP | 3 | tablet | Generic drugs (ANDA) | April 29, 2015 |
| Rising Pharma Holdings, Inc. | 3 | tablet | Authorized generics (NDA) | September 21, 2023 |
| Zydus Lifesciences Limited | 3 | tablet | Generic drugs (ANDA) | June 17, 2025 |
| Zydus Pharmaceuticals USA Inc. | 3 | tablet | Generic drugs (ANDA) | June 17, 2025 |
| Accord Healthcare Inc. | 2 | tablet | Generic drugs (ANDA) | April 29, 2015 |
| Actavis Pharma, Inc. | 2 | tablet | New drug applications (NDA) | April 6, 2009 |
| American Health Packaging | 2 | tablet | Generic drugs (ANDA) | December 9, 2022 |
| Aphena Pharma Solutions - Tennessee, LLC | 2 | tablet | Generic drugs (ANDA) | April 6, 2009 |
| Aphena Pharma Solutions - Tennessee, LLC | 2 | tablet | Generic drugs (ANDA) | January 8, 2026 |
| Aurobindo Pharma Limited | 2 | tablet | Generic drugs (ANDA) | April 14, 2025 |
| AvPAK | 2 | tablet | Generic drugs (ANDA) | October 6, 2026 |
| Bryant Ranch Prepack | 2 | tablet | Generic drugs (ANDA) | June 27, 2003 |
| Camber Pharmaceuticals, Inc. | 2 | tablet | Generic drugs (ANDA) | August 3, 2023 |
| Chartwell RX, LLC | 2 | tablet | Generic drugs (ANDA) | May 11, 2006 |
| Dr. Reddy's Laboratories Limited | 2 | tablet | Generic drugs (ANDA) | October 1, 2009 |
| Harman Finochem Limited | 2 | tablet | Generic drugs (ANDA) | October 6, 2023 |
| Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc. | 2 | tablet | Generic drugs (ANDA) | September 22, 2020 |
| Major Pharmaceuticals | 2 | tablet | Generic drugs (ANDA) | February 8, 2018 |
| Mylan Institutional Inc. | 2 | tablet | Generic drugs (ANDA) | April 29, 1997 |
| Mylan Pharmaceuticals Inc. | 2 | tablet | Generic drugs (ANDA) | October 24, 1986 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 2 | tablet | Generic drugs (ANDA) | June 27, 2003 |
| NorthStar Rx LLC | 2 | tablet | Generic drugs (ANDA) | July 1, 2022 |
| PD-Rx Pharmaceuticals, Inc. | 2 | tablet | Generic drugs (ANDA) | April 14, 2025 |
| Par Health USA, LLC | 2 | tablet | Generic drugs (ANDA) | June 27, 2003 |
| Proficient Rx LP | 2 | tablet | New drug applications (NDA) | April 6, 2009 |
| Safecor Health, LLC | 2 | tablet | Generic drugs (ANDA) | March 19, 2026 |
| Sportpharm LLC | 2 | tablet | Generic drugs (ANDA) | April 14, 2025 |
| Sun Pharmaceutical Industries, Inc. | 2 | tablet | Generic drugs (ANDA) | January 9, 1987 |
| Unichem Pharmaceuticals (USA), Inc. | 2 | tablet | Generic drugs (ANDA) | March 12, 2019 |
| XLCare Pharmaceuticals, Inc. | 2 | tablet | Generic drugs (ANDA) | January 8, 2026 |
| Aphena Pharma Solutions - Tennessee, LLC | 1 | tablet | Generic drugs (ANDA) | October 24, 1986 |
| Fresenius Kabi USA, LLC | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | March 14, 2022 |
| Gland Pharma Limited | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | January 26, 2022 |
| Mylan Institutional LLC | 1 | injection, powder, lyophilized, for solution | New drug applications (NDA) | May 15, 2007 |
| Northwind Health Company, LLC | 1 | tablet | Generic drugs (ANDA) | January 12, 2026 |
| NuCare Pharmaceuticals, Inc. | 1 | tablet | Generic drugs (ANDA) | April 29, 2015 |
| Redpharm Drug | 1 | tablet | Generic drugs (ANDA) | September 22, 2020 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 171 | 98.3% |
| Injection, powder, lyophilized, for solution | 3 | 1.7% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 163 | 93.7% |
| New drug applications (NDA) | 7 | 4% |
| Authorized generics (NDA) | 4 | 2.3% |
Pharmacologic classes
| Class | Products |
|---|---|
| Xanthine Oxidase Inhibitor | 174 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.